Rocket Pharma's SWOT analysis: gene therapy stock faces pivotal year ahead

Rocket Pharma, a gene therapy company, is at a critical juncture—this year could make or break its stock. A SWOT analysis (that’s strengths, weaknesses, opportunities, and threats) suggests the company has promising tech but faces stiff competition and regulatory hurdles. Investors are watching closely to see if its treatments can deliver on their potential or stumble under pressure.